Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice

Johansen, Jeanette Schultz; Harris, Alex K.; Rychly, David J.; Ergul, Adviye
January 2005
Cardiovascular Diabetology;2005, Vol. 4, p5
Academic Journal
Cardiovascular complications, characterized by endothelial dysfunction and accelerated atherosclerosis, are the leading cause of morbidity and mortality associated with diabetes. There is growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia, causes oxidative stress, which further exacerbates the development and progression of diabetes and its complications. Overproduction and/or insufficient removal of these free radicals result in vascular dysfunction, damage to cellular proteins, membrane lipids and nucleic acids. Despite overwhelming evidence on the damaging consequences of oxidative stress and its role in experimental diabetes, large scale clinical trials with classic antioxidants failed to demonstrate any benefit for diabetic patients. As our understanding of the mechanisms of free radical generation evolves, it is becoming clear that rather than merely scavenging reactive radicals, a more comprehensive approach aimed at preventing the generation of these reactive species as well as scavenging may prove more beneficial. Therefore, new strategies with classic as well as new antioxidants should be implemented in the treatment of diabetes.


Related Articles

  • Adiponectin-induced secretion of interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1, CCL2) and interleukin-8 (IL-8, CXCL8) is impaired in monocytes from patients with type I diabetes. Abke, Sabine; Neumeier, Markus; Weigert, Johanna; Wehrwein, Gabriele; Eggenhofer, Elke; Schäffler, Andreas; Maier, Kevin; Aslanidis, Charalampos; Schölmerich, Jürgen; Buechler, Christa // Cardiovascular Diabetology;2006, Vol. 5, p17 

    Background: Systemic adiponectin is reduced in patients with cardiovascular disease (CVD) and low adiponectin may contribute to the pathogenesis of atherosclerosis. However, circulating adiponectin is elevated in type 1 diabetes (T1D) patients, who have also a higher incidence to develop CVD....

  • The primary prevention of CVD for patients with diabetes. Barwell, Nick; Fisher, Miles // GP: General Practitioner;6/2/2006, p38 

    The article presents authors' view related to the primary prevention of cardiovascular disease (CVD) for patients with diabetes. Cardiovascular death in patients with diabetes is elevated threefold compared with the general population. The treatment of patients with diabetes should therefore...

  • Vitamin E, Its Beneficial Role in Diabetes Mellitus (DM) and Its Complications. BABURAO JAIN, ANAND; ANAND JAIN, VAISHALI // Journal of Clinical & Diagnostic Research;Dec2012, Vol. 6 Issue 10, p1624 

    Introduction: Studies have shown that diabetes is accompanied by an increased oxidative damage to all the bimolecular. Enhanced oxidative stress contributes to the development of the diabetic complications. The key lipid soluble chain breaking antioxidant,-tocopherol, is known to be deficient in...

  • An intensive intervention reduced cardiovascular and microvascular events in type 2 diabetes and microalbuminuria. Gaede, P.; Vedel, P.; Larsen, N.; Pedersen, O // Evidence Based Medicine;Sep2003, p142 

    The article presents a study that determines the effectiveness of targeted intensive multifactorial intervention in patients with type 2 diabetes and microalbuminuria compared to conventional treatment. It describes the method of the study that observes 160 patients with type 2 diabetes and...

  • Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Vitale, Cristiana; Mercuro, Giuseppe; Castiglioni, Carlotta; Cornoldi, Alessandra; Tulli, Arianna; Fini, Massimo; Volterrani, Maurizio; Rosano, Giuseppe M. C. // Cardiovascular Diabetology;2005, Vol. 4, p6 

    Background: Metabolic syndrome is a cluster of common cardiovascular risk factors that includes hypertension and insulin resistance. Hypertension and diabetes mellitus are frequent comorbidities and, like metabolic syndrome, increase the risk of cardiovascular events. Telmisartan, an...

  • Multimorbidität bei älteren Rheumapatienten Teil 2. Lakomek, H.-J.; Brabant, T.; Lakomek, M.; Lüttje, D. // Zeitschrift für Rheumatologie;Aug2013, Vol. 72 Issue 6, p539 

    While diseases, such as cardiovascular diseases and osteoporosis in the elderly are categorized as comorbidities of rheumatoid arthritis, elderly rheumatic patients are often additionally affected by thyroid dysfunctions and diabetes mellitus type 2, so that the risk of multimorbidity...

  • Pregnancy glucose warning.  // Pulse;6/18/2008, Vol. 68 Issue 22, p13 

    The article focuses on the findings of two studies regarding the dangers of developing glucose intolerance in women during pregnancy. The studies reveal that glucose intolerance during pregnancy can increase the chances of post-pregnancy diabetes. One of the study also shows that gestational...

  • Non-HDL Cholesterol Is Less Informative Than the Total-to-HDL Cholesterol Ratio in Predicting Cardiovascular Risk in Type 2 Diabetes. Holman, Rury R.; Coleman, Ruth L.; Shine, Brian S. F.; Stevens, Richard J. // Diabetes Care;Jul2005, Vol. 28 Issue 7, p1796 

    Discusses research on the comparison between the usefulness of non-high density lipoprotein (HDL) cholesterol and total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Hazard ratio for non-HDL cholesterol; Difference between the Akaike's Information Criterion of...

  • Analysis of the Degree of Insulin Resistance in Post Menopausal Women by Using Skin Temperature Measurements and Fasting Insulin and Fasting Glucose Levels: A Case Control Study. SATHYA BHAMA, C. V.; BALAJI, S.; SEETHALAKSHMI, A. // Journal of Clinical & Diagnostic Research;Dec2012, Vol. 6 Issue 10, p1644 

    Introduction: In addition to being associated with the termination of the reproductive life in women, menopause coincides with an increase in several co-morbidities which include insulin resistance. An increase in the insulin resistance is associated with an increased risk of diabetes,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics